Weight loss · Once-daily tablet
Wegovy tablets.
Oral semaglutide. Clinically proven weight loss in a once-daily tablet, no needles.
Single pack
Everyone starts here. Your prescriber steps you up only if it suits you.
£107.00per pack
One pack, 30 daily tablets
New patient offer
- Use code FIRSTWL10for £10 off
- Consultation and dose reviews included
- No subscription, reorder when your prescriber agrees
- Next-day tracked delivery
Every price includes your consultation and clinical reviews. Each pack holds 30 daily tablets. Choose a strength to see its price.
Wegovy tablets are a prescription-only medicine. Each pack is dispensed at the strength prescribed for you.
Why Wegovy tablets
The proven GLP-1. Now without the needle.
Wegovy tablets deliver semaglutide, one of the most studied weight-management medicines in the world, in a tablet taken once each morning. Licensed by the MHRA in June 2026, it gives adults living with obesity or overweight a needle-free route to GLP-1 treatment, supervised by our prescribing team.
01
Needle-free.
Clinically proven semaglutide in a tablet you swallow. No pens, no needles, no injection-site reactions.
02
One tablet a day.
Taken first thing on an empty stomach with a sip of water, then wait 30 minutes before eating or drinking. Second nature within days.
03
No fridge.
Stored at room temperature in its blister pack. Easy to keep at home, in a bag or when travelling, with no cold chain to manage.
04
Proven results.
In OASIS 4, adults taking the 25mg tablet as prescribed lost an average of 16.6% of their body weight over 64 weeks, against 2.7% on placebo.
Get the highlights.
OASIS 4, 64 weeks
16.6%
average body-weight loss on the 25mg dose, taking it as prescribed.*
1
tablet each morning, on an empty stomach with a sip of water.
0
needles, and no fridge. Packs keep at room temperature.
24 to 48 hours
from your assessment to your first tablet.
*OASIS 4, 64 weeks on the 25mg dose while taking the medicine as prescribed. Averages: individual results vary.
The evidence
What the OASIS 4 trial showed.
A 64-week phase 3 study of 307 adults with overweight or obesity, comparing the 25mg Wegovy tablet with placebo alongside diet and physical activity. These are averages; individual results vary and no treatment can guarantee a specific outcome.
Average body-weight change in the trial
- Wegovy tablet 25mg, taken as prescribed-16.6%
- Wegovy tablet 25mg, all participants-13.6%
- Placebo with the same diet and activity-2.7%
- 307
- adults in the trial
- 64
- weeks of treatment
- 16.6%
- average loss on the 25mg tablet, taken as prescribed
- 6×
- the loss seen with diet and exercise alone
Weight loss over 64 weeks. The higher figure is for participants who took the medicine as prescribed throughout; the lower includes those who stopped early. For someone weighing 100kg the average is roughly 16 to 17kg. Aronne LJ et al., NEJM 2025.
Your dosing journey
A gradual build-up, exactly as licensed.
Wegovy tablets start at 1.5mg once daily and increase in steps, with at least a month at each level. This gives your body time to adjust and keeps side effects manageable. Most people reach the 25mg maintenance dose at around three months, and your prescriber can hold you at a lower dose for longer if that suits you better.
Month 1
1.5mg
Starting dose, to get used to treatment
Month 2
4mg
Only if tolerated well
Month 3
9mg
Only if tolerated well
Month 4+
25mg
Maintenance dose
Each tablet is taken first thing in the morning on an empty stomach with no more than 120ml of plain water, then at least 30 minutes before eating, drinking anything else or taking other medicines. Doses are only increased if you are tolerating treatment well. The schedule follows the UK Summary of Product Characteristics.
Getting started
Three simple steps.
From your assessment to your first tablet in 24 to 48 hours.
- 1
Free online consultation.
A confidential health questionnaire, completed in minutes. Nothing is charged at this stage.
- 2
Prescriber review.
A UK prescriber checks your suitability, medical history and current medicines, and confirms your starting dose, usually the same day.
- 3
Discreet delivery.
Dispensed by our registered pharmacy and sent next day in plain, tracked packaging. No cold chain needed.
Suitability
Are Wegovy tablets right for you?
Wegovy tablets are a prescription weight-management medicine used alongside diet and exercise, not a quick fix. Under the UK licence they are for adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, prediabetes, type 2 diabetes or obstructive sleep apnoea.
Every order begins with a confidential online assessment reviewed by our prescribing team. If the tablet is not clinically appropriate for you, we will say so and suggest alternatives. The clinical review is a legal requirement and an important safeguard, not a formality.
Quick check before you start
- You are an adult (18 or over) living in the UK
- BMI of 30 or above, or 27 to 30 with a weight-related condition
- Not pregnant, breastfeeding or planning pregnancy
- No history of pancreatitis or medullary thyroid cancer
- Ready to make diet and activity changes alongside treatment
At a glance
- Active ingredient
- Semaglutide (GLP-1), as a tablet
- Doses
- 1.5mg to 25mg, stepped monthly
- Form
- Tablets, 30-day pack, stored at room temperature
- Licence
- MHRA-licensed, June 2026, the UK’s first GLP-1 tablet for weight loss
Safety
Safety at a glance.
Semaglutide has one of the best-documented safety records of any weight loss medicine, built on more than a decade of clinical use. Most side effects are gastrointestinal, mild to moderate, and ease as your body adjusts to each dose.
01
Take the tablet first thing on an empty stomach with no more than 120ml of water, then wait at least 30 minutes before food, drink or other medicines, so it is absorbed properly.
02
Eat smaller, lower-fat meals and stay well hydrated to ease nausea, which usually settles within a few weeks of each dose change.
03
Wegovy must not be used in pregnancy and should be stopped at least two months before trying to conceive. It does not reduce the effectiveness of the contraceptive pill.
04
Seek urgent medical help for severe or persistent abdominal pain, ongoing vomiting or signs of dehydration.
For a full list of side effects, see the patient information leaflet supplied with your pack. Report suspected side effects through the MHRA Yellow Card scheme.
Why Cuva
Safe, regulated care you can trust.
Cuva Health is a pharmacy registered with the General Pharmaceutical Council, operating under the supervision of our Superintendent Pharmacist. Every pack we supply is a genuine, MHRA-licensed medicine sourced through the regulated UK supply chain, prescribed only after clinical review.
UK-regulated prescribing
A GPhC-registered pharmacy supervised by a named Superintendent Pharmacist.
Fast online consultation
Free assessment, reviewed by a UK prescriber, usually within one working day.
Discreet delivery
Plain, tracked packaging, next day to most UK addresses.
Human support
Real people on WhatsApp to help with side effects and taking your tablets.
Registered Pharmacy GPhC 9012581 · Superintendent Pharmacist Irfan Mahmud (GPhC 2080386)
Wegovy tablets questions? Ask a pharmacist.
Straight answers about oral semaglutide, the consultation, dosing, storage and delivery, written by our clinical team.
Or email support@cuvahealth.co.uk
Frequently asked
What is the Wegovy tablet?
The Wegovy tablet is semaglutide, the same GLP-1 medicine as the Wegovy injection, in a tablet taken once each morning. It was licensed by the MHRA in June 2026 for weight management in adults alongside a reduced-calorie diet and increased physical activity, the first GLP-1 tablet for weight loss in the UK.
How much weight could I expect to lose?
In the OASIS 4 trial, adults taking the 25mg tablet as prescribed lost an average of 16.6% of their body weight over 64 weeks, and 13.6% across all participants including those who stopped early. For someone weighing 100kg that is roughly 16 to 17kg, though results vary from person to person.
How does it work?
Semaglutide mimics GLP-1, a hormone your gut releases after eating. It acts on appetite centres in the brain so you feel full sooner and stay satisfied for longer, slows how quickly your stomach empties and quietens food cravings. Taken daily, it keeps a steady effect on appetite.
How and when should I take it?
First thing in the morning on an empty stomach, swallowed whole with no more than 120ml of plain water. Then wait at least 30 minutes before eating, drinking anything else or taking other medicines. Taking it any other way reduces how much is absorbed.
Does the tablet need to be kept in the fridge?
No. Keep it at room temperature in its original blister pack, away from moisture. That makes it easy to keep at home, in a bag or when travelling.
Why does the dose start low and increase?
Starting at 1.5mg and stepping up monthly gives your body time to adjust and keeps side effects, mainly nausea, manageable. Doses are only increased if you are tolerating treatment well, and you can stay on a lower dose if it is working for you.
Does it affect the contraceptive pill?
No. Semaglutide does not reduce exposure to the combined pill, so no additional barrier method is required. Effective contraception still matters, because Wegovy must not be used in pregnancy and should be stopped at least two months before trying to conceive.
What are the most common side effects?
Nausea, diarrhoea, constipation, indigestion and vomiting, usually mild and easing over time. Rarer but serious risks include pancreatitis and gallbladder problems, so seek help quickly for severe or persistent stomach pain. Your medical history is always reviewed before treatment begins.
What happens if I miss a dose?
Skip the missed dose and take your next one the following morning as usual. Do not take two tablets on the same day.
Will I regain weight if I stop?
Some regain is common after stopping any weight loss medicine, because appetite returns. The habits built during treatment make a real difference, and your prescriber can plan a gradual step-down with you rather than stopping abruptly.
Can I switch from an injection to the tablet?
Yes, where it is clinically appropriate. Tell us your current medicine and dose during the consultation and upload a photo of your prescription or packaging, and your prescriber will agree the right tablet dose to move to.
Sources
- Aronne LJ et al. Oral Semaglutide 25 mg in Adults with Overweight or Obesity (OASIS 4). NEJM 2025.
- MHRA, GOV.UK. First GLP-1 tablet for weight loss approved in the UK, 11 June 2026.
- emc. Wegovy tablets Summary of Product Characteristics, sections 4.2, 4.8 and 6.4.
- MHRA Yellow Card scheme.
Ready when you are.
Start with a short, free online assessment. A UK prescriber takes it from there.
Not for emergencies. Call 999, or NHS 111 for urgent advice.